Abstract
INTRODUCTION: Genetic studies conducted over the past four decades have provided us with a detailed catalog of genes that play critical roles in the etiology of Alzheimer's disease (AD) and related dementias (ADRDs). Despite this progress, as a field we have had only limited success in incorporating this rich complexity of human AD/ADRD genetics findings into our animal models of these diseases. Our primary goal for the gene replacement (GR)-AD project is to develop mouse lines that model the genetics of AD/ADRD as closely as possible. METHODS: To do this, we are generating mouse lines in which the genes of interest are precisely and completely replaced in the mouse genome by their full human orthologs. RESULTS: Each model set consists of a control line with a wild-type human allele and variant lines that precisely match the human genomic sequence in the control line except for a high-impact pathogenic mutation or risk variant.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3080-3087 |
| Number of pages | 8 |
| Journal | Alzheimer's and Dementia |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Keywords
- APOE-GR
- APP-GR
- C9ORF72-GR
- MAPT-GR
- PSEN1-GR
- PSEN2-GR
- SNCA-GR
- TARDBP-GR
- TMEM106B-GR
- TREM2-GR
- functional sequence variant
- gene-replacement mouse model
- protective haplotype
- risk haplotype